Form 4 for OPRX OptimizeRx Corp
Accepted 2023-08-18 00:00:00 ET · period of report 2023-06-07 · accession 0001628280-23-029926 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-08-18 | 2023-06-07 | OPRX | Vos Ellen O'Connor | Dir | M - OptEx | $0.00 | +4,637 | 39.4K | +13% | $0 |
| D | 2023-08-18 | 2023-06-07 | OPRX | Vos Ellen O'Connor | Dir | A - Grant | $0.00 | +10.1K | 10.1K | New | $0 |
| D | 2023-08-18 | 2023-06-07 | OPRX | Vos Ellen O'Connor | Dir | M - OptEx | $0.00 | -4,637 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-07 | M | A | 4,637 | $0.00 | 39,427 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 2 | Derivative | Restricted Stock Units | 2023-06-07 | A | A | 10,061 | $0.00 | 10,061 | D | — · — to — | 10,061 Common Stock | (F3) Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock. (F4) The restricted stock units will vest in full on the earlier of the first anniversary of the date of grant or the date of the Company's next annual meeting of shareholders. |
| 3 | Derivative | Restricted Stock Units | 2023-06-07 | M | D | 4,637 | $0.00 | 0 | D | — · — to — | 4,637 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F2) On June 7, 2022 the reporting person was granted 4,637 restricted stock units which vested in full on June 7, 2023. |